UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...

If the tariff-loving Trump goes ahead with his plans, it will hit AstraZeneca - the most valuable company on the UK stock ...

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

InterGrain is progressing two major capital works projects, aimed at boosting capacity and expanding the range of crops in ...

Many drugs use active ingredients that are manufactured outside the U.S., among them the anticoagulant heparin, which 12 million patients use each year. Meanwhile, AstraZeneca's Chairman Michel Demaré ...